This systematic review examines secondary prevention strategies for osteoporosis in older adults with hip fractures, suggesting improvements for better management.
Pharmacological treatment reduces refracture rates in older adults with hip fractures, especially when initiated through FLS. Although bisphosphonates are most commonly studied, anabolic and other antiresorptive agents also show benefits. Improved reporting on BMD follow-up and adherence is needed to guide long-term osteoporosis management.
No takes yet. Share an insight, caveat, or question.
Hosseinzadeh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: